Market Capitalization (Millions $) |
16 |
Shares
Outstanding (Millions) |
49 |
Employees |
- |
Revenues (TTM) (Millions $) |
0 |
Net Income (TTM) (Millions $) |
-21 |
Cash Flow (TTM) (Millions $) |
-15 |
Capital Exp. (TTM) (Millions $) |
1 |
Aim Immunotech Inc
Aim Immunotech Inc is a biotechnology company that focuses on the development and commercialization of novel drugs for the treatment of various diseases. The company's main focus is on developing therapies that modulate the immune system to fight diseases such as cancer, viral infections, and immune disorders. Aim Immunotech Inc utilizes its proprietary technology called Ampligen to stimulate the immune response and enhance the effectiveness of immunotherapies. The company's goal is to provide innovative and effective treatment options for patients with unmet medical needs.
Company Address: 2117 SW Highway 484 Ocala 34473 FL
Company Phone Number: 448-7797 Stock Exchange / Ticker: NYSE AIM
AIM is expected to report next financial results on March 30, 2024. |
|
|